Clinical use in COVID-19
In COVID-19 patients, the use of glucocorticoids (GCs) is rather
controversial (172,173). Early-start of GCs could be helpful for
patients who have an overly exuberant inflammatory response or are at
high risk of developing ARDS, whereas the benefit of GCs as rescue
treatment remains doubtful (174).